CF PharmTech (02652.HK) Reports Share Repurchase and Issued Shares Update

Bulletin Express
Feb 20

CF PharmTech (02652.HK) disclosed that on 20 February 2026, it repurchased 8,000 shares on the Hong Kong Stock Exchange at an average price of HKD 36.28 per share. The highest repurchase price was HKD 36.50, the lowest was HKD 36.08, and the total consideration amounted to HKD 290,260.00. The repurchased shares were placed in treasury, bringing the total treasury shares to 0.36 million.

Following the transaction, the number of issued shares excluding treasury shares decreased to 301.86 million, while the total issued share count remained at 302.22 million. The repurchase falls under a mandate dated 16 December 2025, which authorizes up to 30.22 million shares. The company is subject to a moratorium until 22 March 2026 regarding the issuance of new shares or the sale of any treasury shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10